NCT00865618 Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions Status COMPLETED Phase PHASE1
NCT00865176 Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00865033 A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00864981 A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00864006 Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00861939 To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00858195 A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules Status COMPLETED Phase PHASE1
NCT00857428 Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions Status COMPLETED Phase PHASE1
NCT00857142 Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions Status COMPLETED Phase PHASE1
NCT00711958 Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients Status COMPLETED Phase PHASE3
NCT00701714 Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients Status TERMINATED Phase PHASE3
NCT00666835 Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients Status COMPLETED Phase PHASE3
NCT00632125 Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v. Status COMPLETED Phase PHASE4
NCT00537914 Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA) Status COMPLETED Phase PHASE4
NCT00002268 A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria Status COMPLETED Phase PHASE1
NCT00002263 A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine Status COMPLETED Phase NA
NCT00002258 A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia Status COMPLETED Phase PHASE1
NCT00002253 A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study. Status COMPLETED Phase NA